Hospital General Nuestra Señora del Prado
Talavera de la Reina, Toledo, 45600, Spain
NCT Number: NCT02971215
The purpose of this study is to assess the effectiveness of high intensity laser therapy in the treatment of subacromial impingement syndrome.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Talavera de la Reina, Toledo, 45600, Spain
Shoulder pain has a high prevalence in our society, several studies estimate an annual prevalence between 5% and 47%. It is one of the main causes of musculoskeletal pain, particularly in third place, after the low back pain and neck pain.
Symptoms of pathologies of subacromial space impingement syndrome, where, regardless of origin, pain is the number one symptom for the patient, which emanates functional impairment and the impact on quality of life. Because of the need to implement research to assess the effectiveness of high intensity laser therapy with new studies mayor methodological quality of obtaining conclusive results, and based on the scientific evidence supporting the low-power laser therapy as a useful tool in addressing the shoulder tendon pathology, we consider very interesting the realization of this research project.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Treatment during 15 sessions. It is divided in two phases: 1. 12W. 50 Hz 20% duty cycle. 50 J/cm² in painful zone. 2. 15 W. Burst (10 pulses-900 msec each train) 250 J/cm² in painful zone. Trough the iLux Laser (Mectronic Medicale, Italy)
+ Physical Therapy protocol.
Sham treatment during 15 sessions trough the iLux Laser (Mectronic Medicale, Italy), It is applies the same time than experimental one but with 0 W + Physical Therapy protocol.
Time frame: Baseline
SPADI test
Time frame: At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
SPADI test
Time frame: one month after the end of the protocol treatment
SPADI test
Time frame: three months after the end of the protocol treatment
SPADI test
Time frame: Baseline
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
Time frame: At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
Time frame: one month after the end of the protocol treatment
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
Time frame: three months after the end of the protocol treatment
Constant-Murley Score without strength section. The results will be expressed on a maximum of 75 points.
Time frame: Baseline
Quick- Dash Abbreviated test
Time frame: At the end of the laser protocol treatment (1 daily session during 15 workday -from monday to friday-)
Quick- Dash Abbreviated test
Time frame: one month after the end of the protocol treatment
Quick- Dash Abbreviated test
Time frame: three months after the end of the protocol treatment
Quick- Dash Abbreviated test
Time frame: Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.
Time frame: First session - 15 minutes after laser or sham treatment.
The pressure pain threshold will be measured by a pressure algometer and will be expressed in Newton.
Time frame: Baseline, at the of the 15 sessions, one month after the end of the protocol treatment, three months after the end of the protocol treatment
Visual analogue scale
Time frame: Baseline
EQ-5D™ is a standardised instrument for use as a measure of health outcome.
University of Castilla-La Mancha
Other
Effectiveness of High Intensity Laser Therapy in the Treatment of Subacromial Impingement Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06926465
Joint Diseases, Musculoskeletal Diseases
Giza, Egypt
View Trial DetailsNCT06106048
Joint Diseases, Musculoskeletal Diseases
Sargodha, Pakistan
View Trial DetailsNCT04594408
Joint Diseases, Musculoskeletal Diseases
Winnipeg, Manitoba, Canada
View Trial DetailsNCT05549674
Joint Diseases, Musculoskeletal Diseases
Hvidovre, Denmark
View Trial Details